NO DISPONIBLE : A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP, PLACEBO CONTROLLED (ON INHALED CORTICOSTEROID MEDICATION), MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VILANTEROL INHALATION POWDER (GW642444) AND SALMETEROL, COMPARED WITH PLACEBO IN THE TREATMENT OF PERSISTENT ASTHMA EN ADULTOS Y ADOLESCENTES NO CONTROLADOS CON CORTICOSTEROIDES INHALADOS.

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 05. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Phase: Phase 3
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-09-2010, Last updated: 2023-06-22

ICTRP ID:

PER-070-10
NCT01181895
2010-020412-11

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG004319257